Publications

Schubert, S.Y., Lansky, E.P., Neeman, I., 1999. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. Journal of Ethnopharmacology 66, 11-7.

Kim, N.D., Mehta, R., Yu, W., Neeman, I., Livney, T., Amichay, A., Poirier, D., Nicholls, P., Kirby, A., Jiang, W., Mansel, R., Ramachandran, C., Rabi, T., Kaplan, B., Lansky E., 2002. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Research and Treatment 71, 203-17.

Hora, J.J., Maydew, E.R., Lansky, E.P., Dwivedi, C., 2003. Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. Journal of Medicinal Food 6, 157-61.

Toi, M., Bando, H., Ramachandran, C., Melnick, S.J., Imai, A., Fife, R.S., Carr, R.E., Oikawa, T., Lansky, E.P., 2003. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 6, 121-8.

van Elswijk, D.A., Schobel, U.P., Lansky, E.P., Irth, H., van derGreef, J., 2004. Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry. Phytochemistry 65, 233-41.

Kawaii, S., Lansky, E.P 2004. Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. Journal of Medicinal Food 7, 13-8.

Mehta, R., Lansky, E.P., 2004. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. European Journal of Cancer Prevention 13, 345-8.

Albrecht, M., Jiang, W.,, Kumi-Diaka, J., Lansky, E.P., Gommersall, L.M., Patel, A., Mansel, R.E., Neeman, I., Geldof, A.A., Campbell, M.J. , 2004. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. Journal of Medicinal Food 7, 274-83.

Lansky, E.P., Jiang, W., Mo, H., Bravo, L., Froom, P., Yu, W., Harris, N.M., Neeman, I., Campbell, M.J., 2005. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Investigational New Drugs 23, 11-20.

Lansky, E.P., Harrison, G., Froom, P., Jiang, W.G., 2005. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Investigational New Drugs 23, 121-2. Erratum in: Investigational New Drugs 2005, 23, 379.

Lansky, E.P., von Hoff, D.D., 2005. Complex and simple. Leukemia Research 29, 601-2.

Aslam, M.N., Lansky, E.P., Varani, J., 2006. Pomegranate as a cosmeceutical source: pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells. Journal of Ethnopharmacology 103, 311-8.

Lansky, E.P., 2006. Beware of pomegranates bearing 40% ellagic acid. Journal of Medicinal Food 9, 119-22.

Lansky, E.P., Newman, R.A., 2007. Punica granatum (pomegranate) and its potential for the prevention and treatment of cancer and inflammation. Journal of Ethnopharmacology 109, 177-206.

Katz, S.R., Newman, R.A., Lansky, E.P., 2007. Punica granatum: Heuristic treatment for diabetes mellitus. Journal of Medicinal Food 10, 213-7.

Bishayee A, Bhatia D, Thoppil RJ, Darvesh AS, Nevo E, Lansky EP. Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis. 2011 Jun;32(6):888-96. Epub 2011 Mar 9.

Tran HN, Bae SY, Song BH, Lee BH, Bae YS, Kim YH, Lansky EP, Newman RA. Pomegranate (Punica granatum) seed linolenic acid isomers: concentration-dependent modulation of estrogen receptor activity. Endocr Res. 2010 Jan;35(1):1-16.

Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, Wu ZF, Newman RA, Pawlus AD, Yang P, Lansky EP, Merajver SD. Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr Cancer Ther. 2009 Sep;8(3):242-53.